Cannabis Control Commission Kicks Off Major Regulatory Overhaul
Cannabis testing, medical marijuana licensing, advertising rules, and more will be part of discussions
WORCESTER—The Massachusetts Cannabis Control Commission (Commission) on Sept. 17 will begin a series of public meetings to undertake one of the largest efforts to modernize cannabis regulations in Commission history, with topics including cannabis testing protocols, medical marijuana licensing, and registered agent training up for discussion.
The new regulatory round will be the third of 2026 following the extension of delivery license exclusivity in March, and emergency regulations promulgated this month increasing retail ownership caps, as required by Ch. 65 of the Acts of 2026.
“The Commission has already been hard at work in 2026 remodeling our regulations as the industry continues to evolve, and we look forward to taking on a wide range of updates this fall,” Chair Chris Harding said. “Modernizing our regulations will keep us in line with requirements under Ch. 65 but will also allow us to better protect public health and safety, improve the business climate, and increase consumer confidence.”
In a change from previous updates, internal regulatory working groups overseen by individual Commissioners will provide proposed regulatory language for approval or amendment at upcoming public meetings. The change is aimed at speeding up the regulatory process while allowing Commissioners to maintain final authority over policy approvals while adhering to the Open Meeting Law.
The regulatory updates were introduced at the Commission’s Aug. 13 meeting and will continue on Sept. 17 with a review of changes to medical marijuana licensing and the program as a whole. Ch. 65 of the Acts of 2026 ended the vertical integration requirement for medical marijuana establishments, and Commissioners will review a new standalone medical dispensary license type as well as modifications to authorize transfers from adult-use licensees to medical marijuana establishments. Commissioners will also discuss other changes to the medical program, such as eliminating a residency requirement for patients, and improving access for pediatric patients with life-threatening illnesses.
The Commission is also in the process of establishing a new section of 935 CMR dedicated to cannabis testing requirements, bringing the Commission’s testing standards together in one comprehensive regulatory framework. In developing this section, the Commission will consider updates proposed by Commission staff, the Regulatory Testing Working Group, roundtables with Independent Testing Laboratories, and feedback received through recent public testimony and comment. The new section is intended to provide clear, consistent, and more transparent requirements for the testing of cannabis and cannabis products in Massachusetts and will be the focus of a public meeting in early October.
Meetings scheduled through the end of 2026 will tackle other topics outside of the Ch. 65 requirements, including recommendations that emerged from the Red Tape Removal committee convened earlier this year:
- How municipalities may opt-out of allowing cannabis delivery;
- Transporting cannabis over state waterways for Dukes County and Nantucket County;
- Reviewing the annual Responsible Vendor Training (RVT) requirement;
- Allowing for consideration of statewide license caps;
- Advertising, marketing and loyalty program rules;
- Authorizing the sale of cannabis seeds at adult- and medical-use retail stores;
- Combining transporter licenses;
- Considering agent-centric badging;
- Reviewing notices of deficiency requirements.
Commissioners plan to vote on the three sets of draft regulations at a public meeting in December. Following that, the Commission would open the proposed regulations for public comment, followed by a public hearing in early 2027, and a final vote in March.
“The issues that Commissioners will be tackling in this round are some of the most pressing issues facing the state’s evolving cannabis industry, including a major cannabis testing update that will complement recent Commission efforts to bolster product safety,” Executive Director Travis Ahern said. “We look forward to making these important changes as efficiently as possible while the Commission continues ongoing work to launch social consumption licenses and implements updates under Ch. 65 of the Acts of 2026.”
For more information, visit MassCannabisControl.com, contact the Commission by phone (774) 415-0200 or email Commission@CCCMass.com, or follow the agency on Facebook, X, and LinkedIn.
###
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
